Last reviewed · How we verify

NCT05591599: CNN2

Diagnostic Value of Calponin 2 in Identifying Tubal Pregnancies

Status unknown Last updated 16 March 2023
What this trial tests

trial testing calponin 2 in Tubal Pregnancy in 407 participants. Status unknown.

Timeline
5 December 2022
Primary endpoint
31 December 2024
31 January 2025

Quick facts

Lead sponsorMỹ Đức Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment407
Start date5 December 2022
Primary completion31 December 2024
Estimated completion31 January 2025
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

Mỹ Đức Hospital

Who can join

Adults 18 to 35, female only, with Tubal Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ectopic pregnancy (EP) is the implantation of a fertilized egg outside the main cavity of the uterus. EP is one of the most common gynecologic surgical emergencies , and one of leading causes of maternal mortality in the first trimester of pregnancy. Embryo implantation exerts different pressure on uterine and tubal epithelial and smooth muscle cells, calponin 2 (CNN2) expression at the implantation site would differ between intrauterine pregnancy and tubal pregnancy. The investigators conduct this study to find out the diagnostic value of CNN2 in identifying tubal pregnancies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Mỹ Đức Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05591599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing